Author
Centre National de la Recherche ScientifiqueORCID 0000-0002-0063-4404Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Margaux Oberling, Mathieu Landry, Yann Aubert…·Margherita Ghisi
This study identifies PTBP1-CDC42 splicing regulation as a critical factor in AML growth and venetoclax sensitivity, suggesting a therapeutic combination strategy.
Jérémy Bigot, Mathieu Bouttier, Vincent Fregona…·Bastien Gerby
This study identifies CD20 as an actionable target in B-ALL MRD using PDX models and single-cell RNA sequencing, showing anti-CD20 antibodies can eradicate drug-resistant cells.
Clément Larrue, Sarah Mouche, Paolo Angelino…·Jérôme Tamburini
The paper identifies ferritinophagy as a therapeutic target in quiescent leukemic stem cells, showing that inhibiting NCOA4 reduces leukemia.